Pipeline suggests another busy year for Chinese IPOs in the US

Bank of New York Mellon's head of Asia-Pacific DRs says the bank is in talks with some 15 US listing candidates. He also expects innovative Asian products like HDRs, IDRs and Singapore's GlobalQuote board to develop further this year.
Gregory Roath
Gregory Roath

The first China IPO has yet to hit US markets this year, but an industry insider predicts another busy year as many small and mid-size private sector companies continue to favour a listing in New York via American depositary receipts ADRs over markets closer to home.

He is also positive that the key DR market innovations in Asia last year, including Indian DRs, Hong Kong DRs and the ability to trade ADRs in Singapore, will continue to develop as global issuers try to tap into new pools of investable capital outside the US.

Last year marked a record in terms of the number of Chinese companies that listed in the US through...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222